MedTrace Logo

Duke Autoimmunity in Pregnancy Registry

NCT00513591 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 513

Last updated 2019-10-23

No results posted yet for this study

Summary

It is difficult to predict how a women with an autoimmune disease will do during pregnancy. Some women will improve, others will worsen. Some pregnancies progress normally and others become very complicated.

The Duke Autoimmunity in Pregnancy (DAP) Registry will enroll women with autoimmune diseases, such as lupus, rheumatoid arthritis, scleroderma, and Sjogren's syndrome who wish to become, or already are, pregnant. We will follow these women throughout pregnancy to better understand how their autoimmune disease affects their pregnancy, and vice versa.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Megan E. B. Clowse, MD, MPH · Duke University

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2018-11-19
Completion
2018-11-19

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00513591 on ClinicalTrials.gov